FDA Greenlights First Human Trial of Epigenetic Age Reversal Therapy
Life Biosciences, co-founded by Harvard's David Sinclair, receives FDA approval to begin the first human clinical trial of a gene therapy designed to...
7 articles
Life Biosciences, co-founded by Harvard's David Sinclair, receives FDA approval to begin the first human clinical trial of a gene therapy designed to...
NVIDIA and pharmaceutical giant Eli Lilly form a landmark five-year partnership to build an AI co-innovation lab, marking the largest tech-pharma AI...
Sam Altman-backed longevity startup Retro Biosciences doses first participant in Phase 1 trial of RTR242, a therapy designed to restore cellular waste-clearing...
Scientists at UNSW Sydney have developed a gentler form of CRISPR that can turn genes back on by removing chemical tags, offering safer alternatives for...
California Institute for Regenerative Medicine awards $8 million to Kenai Therapeutics for its FDA Fast Track-designated stem cell therapy targeting...
UNSW Sydney researchers develop CRISPR technique that activates silenced genes by removing methyl groups, avoiding the cancer risks of DNA cutting.
Cold Spring Harbor researchers show CAR T-cell therapy can rejuvenate aging intestines by clearing senescent cells, with benefits lasting over a year in mice.